Evolus Inc (GB:0K16)
LSE:0K16
Holding GB:0K16?
Track your performance easily

Evolus (0K16) Similar Shares

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Evolus
$1.07B
-18.63
107.62%
6 Buy
0 Hold
0 Sell
Strong Buy
Revance Therapeutics
$550.07M
-1.66
-38.89%
0 Buy
8 Hold
0 Sell
Hold
Veru
$126.78M
-2.52
1.88%
3 Buy
1 Hold
0 Sell
Strong Buy
Syndax Pharmaceuticals
$1.63B
-5.66
59.55%
10 Buy
1 Hold
0 Sell
Strong Buy
Fate Therapeutics
$351.88M
-1.81
81.76%
3 Buy
9 Hold
0 Sell
Hold
Evolus
$1.04B
-18.63
107.62%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
EOLS
Evolus
16.90
8.76
107.62%
RVNC
Revance Therapeutics
5.28
-3.36
-38.89%
VERU
Veru
0.87
0.02
2.35%
SNDX
Syndax Pharmaceuticals
19.13
7.14
59.55%
FATE
Fate Therapeutics
3.09
1.39
81.76%
GB:0K16
Evolus
16.40
7.64
87.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis